@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .

nalt:10283
  skos:prefLabel "agentes hipoglicémicos"@es, "hypoglycemic agents"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:related nalt:291608 .

nalt:8071
  skos:prefLabel "inhibidores del apetito"@es, "appetite suppressants"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:broader nalt:291608 .

nalt:341570
  skos:prefLabel "efectos contra la obesidad"@es, "anti-obesity effects"@en ;
  a <https://lod.nal.usda.gov/naltv#Topic>, skos:Concept ;
  skos:related nalt:291608 .

nalt:4359
  skos:prefLabel "agentes adrenérgicos"@es, "adrenergic agents"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:related nalt:291608 .

<https://lod.nal.usda.gov/naltv#Chemical>
  rdfs:label "Chemical"@en ;
  a owl:Class .

nalt:286
  skos:prefLabel "medicamentos"@es, "drugs"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:narrower nalt:291608 .

nalt:762
  skos:prefLabel "obesidad"@es, "obesity"@en ;
  a <https://lod.nal.usda.gov/naltv#Topic>, skos:Concept ;
  skos:related nalt:291608 .

nalt:291608
  dc:modified "2020-07-20"^^xsd:date ;
  skos:hiddenLabel "antiobesity drug"@en, "anti-obesity substance"@en, "weight reducing drug"@en, "antiobesity agent"@en, "anti-obesity drug"@en, "weight reducing agent"@en, "antiobesity agents"@en, "weight reducing substances"@en, "anti-obesity agent"@en, "anti-obesity substances"@en ;
  skos:related nalt:341570, nalt:6735, nalt:10283, nalt:762, nalt:4359 ;
  a skos:Concept, <https://lod.nal.usda.gov/naltv#Chemical> ;
  skos:prefLabel "agentes contra la obesidad"@es, "anti-obesity agents"@en ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:narrower nalt:8071 ;
  dc:created "2017-02-07"^^xsd:date ;
  skos:altLabel "weight-loss drugs"@en, "weight-loss agents"@en, "weight-reducing drugs"@en ;
  skos:broader nalt:286 ;
  ns0:marc001 "79944" ;
  skos:definition nalt:291608_def .

nalt:6735
  skos:prefLabel "diabetes mellitus"@es, "diabetes mellitus"@en ;
  a ns0:Topic, skos:Concept ;
  skos:related nalt:291608 .

<https://lod.nal.usda.gov/nalt>
  rdfs:label "NALT Full"@en ;
  a skos:ConceptScheme .

nalt:291608_def
  rdf:value "Agentes que aumentan el gasto energético y la pérdida de peso mediante una regulación neuronal y química. Los agentes betaadrenérgicos y los fármacos serotoninérgicos han sido empleados de manera experimental en pacientes con diabetes mellitus no dependiente de la insulina (DMNDI) para tratar la obesidad."@es, "Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (NIDDM) to treat obesity."@en ;
  dc:source "Medical Subject Headings 2017" ;
  a ns0:Definition .